Home / Health / FDA Greenlights Bemotrizinol for Sunscreen
FDA Greenlights Bemotrizinol for Sunscreen
10 Jun
Summary
- FDA approved bemotrizinol, a new sunscreen ingredient.
- Bemotrizinol offers protection against UVA and UVB rays.
- It is considered safe for adults and children six months plus.
The U.S. Food and Drug Administration announced on Tuesday, June 9, that bemotrizinol has been added to the list of permitted sunscreen active ingredients. This approval is significant as it is the first new active ingredient authorized for over-the-counter sunscreen products since the late 1990s.
Bemotrizinol offers comprehensive protection against both ultraviolet A (UVA) and ultraviolet B (UVB) rays. The ingredient is noted for its low absorption rate through the skin into the body, with the agency deeming it safe for use by adults and children as young as six months old.
Health and Human Services Secretary Robert F. Kennedy Jr. stated that bemotrizinol has a long history of safe use in Europe for decades. He anticipates that this FDA action will stimulate greater competition and enhance consumer confidence in the available sunscreen products.
